Cited by 373Cancer Genomics and DiagnosticsAdvanced biosensing and bioanalysis techniquesExtracellular vesicles in disease

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Isolation and characterization of DNA from the plasma of cancer patients

Stroun, Maurice, Anker, Philippe, Lyautey, Jacqueline, Lederrey, Christine, Maurice, Pierre A.·1987·European Journal of Cancer and Clinical Oncology

DOI 10.1016/0277-5379(87)90266-5

Open this paper in CoChat — free account

Abstract

Unlabelled Ten out of 37 patients with advanced malignant diseases were found to have extractable amounts of DNA in their plasma whereas no DNA could be detected in 50 normal controls. After its purification from the original nucleoprotein complex, DNA plasma levels ranging from 0.15 to 12 micrograms/ml were measured, the lowest concentration detectable with our method being 0.1 microgram/ml. Knowing from recovery experiments performed with 32P-DNA that the loss of DNA during the extraction procedure is about 65%, the real concentration of DNA in the plasma corresponds to about 3 times the given figures. The purified DNA was shown to be double-stranded and composed of fractions ranging from 21 kb to less than 0.5 kb, as determined by agarose gel electrophoresis. All these fractions hybridized with a 32P-labelled human DNA probe indicating the human origin of the bulk of the circulating DNA.In conclusion the finding of extractable amounts of DNA in the plasma of 27% of the investigated cancer patients, and its absence from the controls, suggests some correlation with malignancy.

Integrity signals

Registry

Crossref · 10.1016/0277-5379(87)90266-5

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I
Rigby, P. W. J., Dieckmann, M., Rhodes, C., & Berg, P. R. (1977) · Journal of Molecular Biology · doi:10.1016/0022-2836(77)90052-3 · Cited by 11,400
Untitled work
(1977) · PubMed · Cited by 1,801
Spontaneous release of DNA by human blood lymphocytes as shown in an in vitro system.
Anker, P., Stroun, M., & Maurice, P. A. (1975) · PubMed · Cited by 234
Self-citation
Excretion of Deoxyribonucleic Acid by Lymphocytes Stimulated with Phytohemagglutinin or Antigen
ROGERS, J. C., Boldt, D. H., Kornfeld, S. A., Skinner, S. A. M., & VALERI, C. R. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.7.1685 · Cited by 158
Circulating Nucleic Acids in Higher Organisms
Stroun, M., Anker, P., Maurice, P. A., & Gahan, P. B. (1977) · International review of cytology · doi:10.1016/s0074-7696(08)60225-9 · Cited by 106
Self-citation
Circulating DNA in systemic lupus erythematosus. Isolation and characterization.
Steinman, C. R. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111278 · Cited by 99
Isolation and characterization of an RNA-proteolipid complex associated with the malignant state in humans.
Wieczorek, A. J., Rhyner, C., & Block, L. H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.10.3455 · Cited by 97
Circulating DNA in systemic lupus erythematosus
Steinman, C. R. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)90789-7 · Cited by 95
Cell-surface-associated nucleic acid in tumorigenic cells made visible with platinum-pyrimidine complexes by electron microscopy.
Aggarwal, S. K., Wagner, R. W., McAllister, P. K., & Rosenberg, B. H. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.3.928 · Cited by 79
Nucleic acids spontaneously released by living frog auricles
Stroun, M., & Anker, P. (1972) · Biochemical Journal · doi:10.1042/bj1280100pb · Cited by 69
Self-citation

Show all 17 references

Research works printed but not linked: 1

Carpentier, 1981, The presence of circulating DNA in patients with acute or chronic leukemia: relation to serum anti-DNA antibodies and Clq binding activity, Human Lymphocyte Differentiation, 1, 93

Sorted by citations

A view on drug resistance in cancer
Vasan, N., Baselga, J., & Hyman, D. M. (2019) · Nature · doi:10.1038/s41586-019-1730-1 · Cited by 2,770
Direct detection of early-stage cancers using circulating tumor DNA
Phallen, J. A., Sausen, M., Adleff, V., Leal, A., Hruban, C., White, J. R., Anagnostou, V., Fiksel, J., Cristiano, S., Papp, E., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan2415 · Cited by 1,149
Origins, structures, and functions of circulating DNA in oncology
Thierry, A. R., El Messaoudi, S., Gahan, P. B., Anker, P., & Stroun, M. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9629-x · Cited by 818
Self-citation
High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
Razavi, P., Li, B. T., Brown, D. N., Jung, B., Hubbell, E. A., Shen, R., Abida, W. M., Juluru, K., de Bruijn, I., Hou, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0652-7 · Cited by 808
Advances in bladder cancer biology and therapy
Tran, L. L., Xiao, J.-F., Agarwal, N., Duex, J. E., & Theodorescu, D. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-00313-1 · Cited by 758
Analytical and clinical validation of a digital sequencing panel for quantitative, highly accurate evaluation of cell-free circulating tumor DNA
Lanman, R. B., Mortimer, S. A., Zill, O. A., Sebisanovic, D., Lopez, R., Blau, S., Collisson, E. A., Divers, S. G., Hoon, D. S. B., Kopetz, E. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140712 · Cited by 695
Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
Haber, D. A., & Velculescu, V. E. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-1014 · Cited by 710
Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
Thierry, A. R., Mouliere, F. C., Messaoudi, S. E., Mollévi, C., Lopez‐Crapez, E., Rolet, F., Gillet, B., Gongora, C., Dechelotte, P., Robert, B., et al. (2014) · Nature Medicine · doi:10.1038/nm.3511 · Cited by 687
Microsatellite alterations in serum DNA of head and neck cancer patients
Nawroz, H., Koch, W. M., Anker, P., Stroun, M., & Sidransky, D. (1996) · Nature Medicine · doi:10.1038/nm0996-1035 · Cited by 656
Self-citation
Circulating cell free DNA: Preanalytical considerations
Messaoudi, S. E., Rolet, F., Mouliere, F. C., & Thierry, A. R. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.05.022 · Cited by 578
Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations
Salk, J. J., Schmitt, M. W., & Loeb, L. A. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2017.117 · Cited by 551
Detection and Clinical Importance of Micrometastatic Disease
Pantel, K., Côté, R. J., & Fodstad, Ø. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.13.1113 · Cited by 493
Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation
Whale, A. S., Huggett, J. F., Cowen, S., Speirs, V., Shaw, J., Ellison, S., Foy, C. A., & Scott, D. J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks203 · Cited by 453
Detection of Circulating Tumour DNA in the Blood (Plasma/Serum) of Cancer Patients
Anker, P., Mulcahy, H. E., Chen, X. Q., & Stroun, M. (1999) · Cancer and Metastasis Reviews · doi:10.1023/a:1006260319913 · Cited by 451
Self-citation
Circulating free DNA in plasma or serum as biomarker of carcinogenesis: Practical aspects and biological significance
Gormally, E., Caboux, É., Vineis, P., & Hainaut, P. L. (2007) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2006.11.002 · Cited by 444
Point mutations of the N‐ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia
Vasioukhin, V. I., Anker, P., Maurice, P. A., Lyautey, J., Lederrey, C., & Stroun, M. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb04828.x · Cited by 413
Self-citation
Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients.
Rosas, S. L. B., Koch, W. M., Carvalho, M. D. G., Wu, L., Califano, J. A., Westra, W. H., Jen, J., & Sidransky, D. (2001) · PubMed · Cited by 409
Nucleic Acid-Based Methods for the Detection of Cancer
Sidransky, D. (1997) · Science · doi:10.1126/science.278.5340.1054 · Cited by 403
The Origin and Mechanism of Circulating DNA
Stroun, M., Maurice, P. A., Vasioukhin, V. I., Lyautey, J., Lederrey, C., Lefort, F., ROSSIER, A., Chen, X. Q., & Anker, P. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06608.x · Cited by 395
Self-citation
Cell-free DNA in the blood as a solid tumor biomarker–a critical appraisal of the literature
Jung, K., Fleischhacker, M., & Rabien, A. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.07.032 · Cited by 337
The diverse origins of circulating cell‐free DNA in the human body: a critical re‐evaluation of the literature
Aucamp, J., Bronkhorst, A. J., Badenhorst, C. P. S., & Pretorius, P. J. (2018) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12413 · Cited by 338
Circulating nucleic acids (CNAs) and cancer—A survey
Fleischhacker, M., & Schmidt, B. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.10.001 · Cited by 851
The Long and Short of Circulating Cell-Free DNA and the Ins and Outs of Molecular Diagnostics
Jiang, P., & Lo, Y. M. D. (2016) · Trends in Genetics · doi:10.1016/j.tig.2016.03.009 · Cited by 316
Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma
Lee, T., Montalvo, L., Chrebtow, V., & Busch, M. P. (2001) · Transfusion · doi:10.1046/j.1537-2995.2001.41020276.x · Cited by 311
Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients
Zhang, Y., Yao, Y., Xu, Y., Li, L., Gong, Y., Zhang, K., Zhang, M., Guan, Y., Chang, L., Xia, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20162-8 · Cited by 312
Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts
Thierry, A. R., Mouliere, F. C., Gongora, C., Ollier, J., Robert, B., Ychou, M., Rio, M. D., & Molina, F. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq421 · Cited by 299
Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification
Devonshire, A. S., Whale, A. S., Gutteridge, A., Jones, G. M., Cowen, S., Foy, C. A., & Huggett, J. F. (2014) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-7835-3 · Cited by 308
Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology
Deveson, I. W., Gong, B., Lai, K., LoCoco, J. S., Richmond, T., Schageman, J. J., Zhang, Z., Novoradovskaya, N., Willey, J. C., Jones, W. D., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00857-z · Cited by 288
An electrochemical clamp assay for direct, rapid analysis of circulating nucleic acids in serum
Das, J., Ivanov, I., Montermini, L., Rak, J. W., Sargent, E. H., & Kelley, S. O. (2015) · Nature Chemistry · doi:10.1038/nchem.2270 · Cited by 276
Guidelines for the Preanalytical Conditions for Analyzing Circulating Cell-Free DNA
Meddeb, R., Pisareva, E., & Thierry, A. R. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2018.298323 · Cited by 263
Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective
Postel, M., Roosen, A., Laurent‐Puig, P., Taly, V., & Renault, S. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1400384 · Cited by 255
Genomic Medicine–Progress, Pitfalls, and Promise
Shendure, J., Findlay, G. M., & Snyder, M. W. (2019) · Cell · doi:10.1016/j.cell.2019.02.003 · Cited by 263
Quantitative Cell-Free Circulating BRAFV600E Mutation Analysis by Use of Droplet Digital PCR in the Follow-up of Patients with Melanoma Being Treated with BRAF Inhibitors
Sanmamed, M. F., Landazuri, S. F., Rodríguez, C., Zárate, R., Lozano, M. D., Zubiri, L., Perez‐Gracia, J. L., Martín‐Algarra, S., & González, Á. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2014.230235 · Cited by 249
Quantifying circulating cell-free DNA in humans
Meddeb, R., Dache, Z. A. A., Thézenas, S., Otandault, A., Tanos, R., Pastor, B., Sánchez, C., Azzi, J., Tousch, G., Azan, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-41593-4 · Cited by 242
Human Urine Contains Small, 150 to 250 Nucleotide-Sized, Soluble DNA Derived from the Circulation and May Be Useful in the Detection of Colorectal Cancer
Su, Y., Wang, M., Brenner, D. E., Ng, A. K. L., Melkonyan, H. S., Umansky, S. R., Syngal, S., & Block, T. M. (2004) · Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60497-7 · Cited by 240
Multi‐marker analysis of circulating cell‐free DNA toward personalized medicine for colorectal cancer
Mouliere, F. C., Messaoudi, S. E., Pang, D., Dritschilo, A., & Thierry, A. R. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.02.005 · Cited by 234
Cell-free DNA: measurement in various carcinomas and establishment of normal reference range
Wu, T., Zhang, D., Chia, J., Tsao, K., Sun, C., & Wu, J. T. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(02)00091-8 · Cited by 231
Circulating DNA: a new diagnostic gold mine?
Ziegler, A., Zangemeister‐Wittke, U., & Stahel, R. A. (2002) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(02)00077-4 · Cited by 229
Putative Origins of Cell-Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms
Grabuschnig, S., Bronkhorst, A. J., Holdenrieder, S., Rodriguez, I. R., Schliep, K. P., Schwendenwein, D., Ungerer, V., & Sensen, C. W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218062 · Cited by 237
Extracellular DNA and histones: double‐edged swords in immunothrombosis
Gould, T. J., Lysov, Z., & Liaw, P. C. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12977 · Cited by 226
Circulating Cell-Free DNA
Breitbach, S. A., Tug, S., & Simon, P. D. (2012) · Sports Medicine · doi:10.2165/11631380-000000000-00000 · Cited by 218
A prospective study of K-ras mutations in the plasma of pancreatic cancer patients.
Mulcahy, H. E., Lyautey, J., Lederrey, C., Chen, X. Q., Anker, P., Alstead, E. M., Ballinger, A., Farthing, M. J. G., & Stroun, M. (1998) · PubMed · Cited by 205
Self-citation
Clinical use of circulating nucleosomes
Holdenrieder, S., & Stieber, P. (2009) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360802485875 · Cited by 200
The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells
Choi, J., Reich, C. F., & Pisetsky, D. S. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02130.x · Cited by 199
Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer.
Chen, X., Bonnefoi, H. R., Diebold‐Berger, S., Lyautey, J., Lederrey, C., Faltin-Traub, E. F., Stroun, M., & Anker, P. (1999) · PubMed · Cited by 193
Self-citation
Circulating DNA
van der Vaart, M., & Pretorius, P. J. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.022 · Cited by 196
Ser-249 p53 Mutations in Plasma DNA of Patients With Hepatocellular Carcinoma From The Gambia
Kirk, G. D., Camus-Randon, A.-M., Mendy, M. E., Goedert, J. J., Merle, P., TREPO, C. G., Bréchot, C., Hainaut, P. L., & Montesano, R. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.2.148 · Cited by 190
Extracellular nucleic acids
Vlassov, V. V., Laktionov, P. P., & RYKOVA, E. Y. (2007) · BioEssays · doi:10.1002/bies.20604 · Cited by 183
Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)
Chin, R.-I., Chen, K., Usmani, A., Chua, C., Harris, P. K., Binkley, M. S., Azad, T. D., Dudley, J. C., & Chaudhuri, A. A. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00390-5 · Cited by 191
Genomic analysis of circulating cell-free DNA infers breast cancer dormancyPreprint
Shaw, J., Page, K., Blighe, K., Hava, N., Guttery, D. S., Ward, B., Brown, J., Ruangpratheep, C., Stebbing, J., Payne, R., et al. (2011) · Genome Research · doi:10.1101/gr.123497.111 · Cited by 182
Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer
KOPRESKI, M. S., Benko, F. A., Kwee, C., Leitzel, K. E., Eskander, E., Lipton, A., & Gocke, C. D. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.551 · Cited by 172
Plasma cell‐free DNA in ovarian cancer
Kamat, A. A., Baldwin, M., Urbauer, D. L., Dang, D. H., Han, L. Y., Godwin, A. K., Karlan, B. Y., Simpson, J. L., Gershenson, D. M., Coleman, R. L., et al. (2010) · Cancer · doi:10.1002/cncr.24997 · Cited by 169
The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
Mattox, A. K., Douville, C. B., Wang, Y., Popoli, M., Ptak, J., Silliman, N., Dobbyn, L., Schaefer, J., Lu, S., Pearlman, A. H., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1252 · Cited by 174
Potential clinical utility of liquid biopsies in ovarian cancer
Zhu, J. W., Charkhchi, P., & Akbari, M. R. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01588-8 · Cited by 166
Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
Yamada, T., Nakamori, S., Ohzato, H., Oshima, S., Aoki, T., HIGAKI, N., Sugimoto, K., Akagi, K., Fujiwara, Y., Nishisho, I., et al. (1998) · PubMed · Cited by 159
Circulating Cell-Free DNA in Plasma/Serum of Lung Cancer Patients as a Potential Screening and Prognostic Tool
Kumar, S. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.062893 · Cited by 154
Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 Patients
Schwaederle, M. C., Husain, H., Fanta, P. T., Piccioni, D. E., Kesari, S., Schwab, R. B., Patel, S. P., Harismendy, O., Ikeda, M., Parker, B. A., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0318 · Cited by 154
Blood‐based detection of RAS mutations to guide anti‐ EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue‐based RAS testing
Schmiegel, W., Scott, R. J., Dooley, S., Lewis, W., Meldrum, C. J., Pockney, P. G., Draganic, B. D., Smith, S., Hewitt, C., Phillimore, H., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12023 · Cited by 152
Cell‐free DNA as a biomarker of aging
Teo, Y. V., Capri, M., Morsiani, C., Pizza, G., Faria, A. M. C., Franceschi, C., & Neretti, N. (2019) · Aging Cell · doi:10.1111/acel.12890 · Cited by 127
The aflatoxin-induced TP53 mutation at codon 249 (R249S): Biomarker of exposure, early detection and target for therapy
Gouas, D. A., Shi, H., & Hainaut, P. L. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.057 · Cited by 151
Circulating biomarkers to monitor cancer progression and treatment
Rapisuwon, S., Vietsch, E. E., & Wellstein, A. (2016) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2016.05.004 · Cited by 143
Application of liquid biopsy in precision medicine: opportunities and challenges
Wang, J., Chang, S., Li, G., & Sun, Y. (2017) · Frontiers of Medicine · doi:10.1007/s11684-017-0526-7 · Cited by 140
Utility of Genomic Analysis In Circulating Tumor DNA from Patients with Carcinoma of Unknown Primary
Kato, S., Krishnamurthy, N., Banks, K. C., De, P. K., Williams, K. A., Williams, C. B., Leyland-Jones, B. R., Lippman, S. M., Lanman, R. B., & Kurzrock, R. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0628 · Cited by 134
Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer
Paci, M., Maramotti, S., Bellesia, E., Formisano, D., Albertazzi, L., Ricchetti, T., Ferrari, G., Annessi, V., Lasagni, D., Carbonelli, C. M., et al. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.07.012 · Cited by 133
Biomarkers for early detection of breast cancer: What, when, and where?
LEVENSON, V (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.01.017 · Cited by 131
Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients
Silva, J. M., Domínguez, G., Villanueva, M. J., Gonzalez, R., Garcia, J. M., Corbacho, C., Provencio, M., España, P., & Bonilla, F. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690495 · Cited by 131
Liquid biopsy for cancer screening, patient stratification and monitoring
Brock, G., Castellanos-Rizaldos, E., Hu, L., Coticchia, C. M., & Skog, J. (2018) · Translational Cancer Research · doi:10.21037/4546 · Cited by 130
An Overview on the Isolation and Analysis of Circulating Tumor DNA in Plasma and Serum
Jen, J., Wu, L. J., & Sidransky, D. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06581.x · Cited by 128
Measurement of an apoptotic product in the sera of breast cancer patients
Ueno, T., Toi, M., Bivén, K., Bando, H., Ogawa, T., & Linder, S. T. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00865-1 · Cited by 127
Circulating cell-free DNA: A novel biomarker for response to therapy in ovarian carcinoma
Kamat, A. A., Bischoff, F. Z., Dang, D., Baldwin, M. R., Han, L. Y., Lin, Y. G., Merritt, W. M., Landen, C. N., Lu, C., Gershenson, D. M., et al. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.10.3240 · Cited by 127
Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients
Marzese, D. M., Hirose, H., & Hoon, D. S. �. (2013) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2013.845088 · Cited by 123
Circulating DNA fragmentomics and cancer screening
Thierry, A. R. (2023) · Cell Genomics · doi:10.1016/j.xgen.2022.100242 · Cited by 125
Circulating Nucleic Acids in Plasma and Serum
Gahan, P. B., & Swaminathan, R. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.050 · Cited by 121
Circulating Mitochondrial Nucleic Acids Have Prognostic Value for Survival in Patients with Advanced Prostate Cancer
Mehra, N., Penning, M. T., Maas, J., van Daal, N., Giles, R. H., & Voest, E. E. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1087 · Cited by 115
Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients
Benešová, L., Belšánová, B., Suchánek, Š., Kopeckova, M., Mináriková, P., Lipská, L., Levý, M., Visokai, V., Zavoral, M., & Minárik, M. (2012) · Analytical Biochemistry · doi:10.1016/j.ab.2012.06.018 · Cited by 109
Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients.
Fujiwara, Y., Chi, D. D., Wang, H., Keleman, P., Morton, D. L., Turner, R. R., & Hoon, D. S. �. (1999) · PubMed · Cited by 108
Recovering circulating extracellular or cell-free RNA from bodily fluids
Tzimagiorgis, G., Michailidou, E. Z., Κritis, A., Markopoulos, A. K., & Kouidou, S. (2011) · Cancer Epidemiology · doi:10.1016/j.canep.2011.02.016 · Cited by 109
The epigenetics of oral cancer
Shaw, R. (2005) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2005.06.014 · Cited by 107
Cell-Free DNA Fragmentomics: The Novel Promising Biomarker
Qi, T., Pan, M., Shi, H., Wang, L., Bai, Y., & Ge, Q. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021503 · Cited by 111
Microsatellite alterations plasma DNA of primary breast cancer patients.
Shaw, J., Smith, B., Walsh, T., Johnson, S., Primrose, L., Slade, M. J., Walker, R. A., & Coombes, R. C. (2000) · PubMed · Cited by 99
Release of DNA from Dead and Dying Lymphocyte and Monocyte Cell Lines In Vitro
Choi, J. ‐., Reich, C. F., & Pisetsky, D. S. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2004.01470.x · Cited by 97
Molecular characterisation and liquid biomarkers in Carcinoma of Unknown Primary (CUP): taking the ‘U’ out of ‘CUP’
Conway, A., Mitchell, C. L., Kilgour, E., Brady, G., Dive, C., & Cook, N. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0332-2 · Cited by 95
Cell free DNA as a diagnostic and prognostic marker for cardiovascular diseases
Polina, I. A., Ilatovskaya, D. V., & DeLeon‐Pennell, K. Y. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.01.013 · Cited by 95
At the dawn: cell-free DNA fragmentomics and gene regulation
Liu, Y. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01635-z · Cited by 102
Role of macrophages in the generation of circulating blood nucleosomes from dead and dying cells
Jiang, N., Reich, C. F., & Pisetsky, D. S. (2003) · Blood · doi:10.1182/blood-2002-10-3312 · Cited by 94
Cell-free DNA approaches for cancer early detection and interception
Medina, J. E., Dracopoli, N. C., Bach, P. B., Lau, A., Scharpf, R. B., Meijer, G. A., Andersen, C. L., & Velculescu, V. E. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006013 · Cited by 94
Quantification of Circulating DNA in the Plasma and Serum of Cancer Patients
Taback, B., O'Day, S. J., & Hoon, D. S. �. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1318.004 · Cited by 91
Genomic and fragmentomic landscapes of cell-free DNA for early cancer detection
Bruhm, D. C., Vulpescu, N. A., Foda, Z. H., Phallen, J. A., Scharpf, R. B., & Velculescu, V. E. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00795-x · Cited by 110
Increased Plasma Circulating Cell-Free DNA Could Be a Potential Marker for Oral Cancer
Lin, L.-H., Chang, K., Kao, S., Cheng, H.-W., & Liu, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113303 · Cited by 91
Detection of mutated KRAS2 sequences as tumor markers in plasma/serum of patients with gastrointestinal cancer.
Sorenson, G. D. (2000) · PubMed · Cited by 85
Real-Time Genomic Characterization Utilizing Circulating Cell-Free DNA in Patients with Anaplastic Thyroid Carcinoma
Sandulache, V. C., Williams, M. D., Lai, S. Y., Lu, C., William, W. N., Busaidy, N. L., Cote, G. J., Singh, R. R., Luthra, R., & Cabanillas, M. E. (2016) · Thyroid · doi:10.1089/thy.2016.0076 · Cited by 84
Increased integrity of circulating cell-free DNA in plasma of patients with acute leukemia
Gao, Y., He, Y., Yang, Z., Shao, H.-Y., Zuo, Y., Bai, Y., Chen, H., Chen, X., Qin, F., Tan, S., et al. (2010) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2010.311 · Cited by 83
Clinical Impact of Hybrid Capture–Based Next-Generation Sequencing on Changes in Treatment Decisions in Lung Cancer
Rozenblum, A. B., Ilouze, M., Dudnik, E., Dvir, A., Soussan‐Gutman, L., Geva, S., & Peled, N. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.10.021 · Cited by 80
Validation of a blood plasma separation system by biomarker detection
Kersaudy-Kerhoas, M., Kavanagh, D. M., Dhariwal, R. S., Campbell, C. J., & Desmulliez, M. P. Y. (2010) · Lab on a Chip · doi:10.1039/b926834k · Cited by 80
Dielectrophoretic isolation and detection of cfc‐ DNA nanoparticulate biomarkers and virus from blood
Sonnenberg, A., Marciniak, J. Y., McCanna, J. P., Krishnan, R., Rassenti, L. Z., Kipps, T. J., & Heller, M. J. (2013) · Electrophoresis · doi:10.1002/elps.201200444 · Cited by 79
Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg?
Bonanno, L., Maso, A. D., Pavan, A., Zulato, E., Calvetti, L., Pasello, G., Guarneri, V., Conte, P., & Indraccolo, S. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01777-8 · Cited by 81
Alternating current electrokinetic separation and detection of DNA nanoparticles in high‐conductance solutions
Krishnan, R., Sullivan, B. D., Mifflin, R. L., Esener, S. C., & Heller, M. J. (2008) · Electrophoresis · doi:10.1002/elps.200800037 · Cited by 79
Measurement of Circulating Cell-Free DNA Levels by a New Simple Fluorescent Test in Patients With Primary Colorectal Cancer
Czeiger, D., Shaked, G., Eini, H., Vered, I., Belochitski, O., Avriel, A., Ariad, S., & Douvdevani, A. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcp4rk2ihvkttzv · Cited by 77
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
Cheng, X., Zhang, L., Chen, Y., & Qing, C. (2017) · Journal of Ovarian Research · doi:10.1186/s13048-017-0369-5 · Cited by 76
Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies
Ralla, B., Stephan, C., Meller, S., Dietrich, D., Kristiansen, G., & Jung, K. (2014) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2014.914888 · Cited by 75

Authors: Stroun, M., Anker, P., Lyautey, J., Lederrey, C., & Maurice, P. A.
Affiliations: University of Geneva (CH)
University Hospital of Geneva (CH)
Venue: European Journal of Cancer and Clinical Oncology
Publisher: Elsevier BV
Published: 1987-06
Volume: 23
Issue: 6
Pages: 707-712
ISSN: 0277-5379 (ISSN-L)
DOI: 10.1016/0277-5379(87)90266-5
OpenAlex: W2058440954
Cited by: 373
References: 17
Citations by year: 2026: 8 · 2025: 9 · 2024: 7 · 2023: 18 · 2022: 16 · 2021: 21 · 2020: 21 · 2019: 29 · 2018: 27 · 2017: 13 · 2016: 13 · 2015: 10 · 2014: 15 · 2013: 11 · 2012: 18
FWCI: 0.00
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: European Journal of Cancer and Clinical Oncology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
Keywords: circulating tumor DNA, plasma DNA, cancer patients, DNA extraction, DNA purification, double-stranded DNA, DNA fragment size distribution, DNA hybridization, malignancy marker
MeSH terms: DNA, Neoplasm, Electrophoresis, Agar Gel, Humans, Neoplasms, Nucleic Acid Hybridization

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Isolation and characterization of DNA from the plasma of cancer patients

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks